119 related articles for article (PubMed ID: 12592387)
1. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and sex chromosome association of CHD3/4 and CHD5 during spermatogenesis.
Bergs JW; Neuendorff N; van der Heijden G; Wassenaar E; Rexin P; Elsässer HP; Moll R; Baarends WM; Brehm A
PLoS One; 2014; 9(5):e98203. PubMed ID: 24849318
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer.
Hashimoto T; Kurokawa Y; Wada N; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
Oncol Lett; 2020 Jan; 19(1):1066-1073. PubMed ID: 31897220
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking the chromodomain helicase DNA-binding 5 chromatin remodeler display autism-like characteristics.
Pisansky MT; Young AE; O'Connor MB; Gottesman II; Bagchi A; Gewirtz JC
Transl Psychiatry; 2017 Jun; 7(6):e1152. PubMed ID: 28608855
[TBL] [Abstract][Full Text] [Related]
5. CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes.
Potts RC; Zhang P; Wurster AL; Precht P; Mughal MR; Wood WH; Zhang Y; Becker KG; Mattson MP; Pazin MJ
PLoS One; 2011; 6(9):e24515. PubMed ID: 21931736
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.
Kolla V; Naraparaju K; Zhuang T; Higashi M; Kolla S; Blobel GA; Brodeur GM
Biochem J; 2015 Jun; 468(2):345-52. PubMed ID: 25825869
[TBL] [Abstract][Full Text] [Related]
7. CHD5 is required for neurogenesis and has a dual role in facilitating gene expression and polycomb gene repression.
Egan CM; Nyman U; Skotte J; Streubel G; Turner S; O'Connell DJ; Rraklli V; Dolan MJ; Chadderton N; Hansen K; Farrar GJ; Helin K; Holmberg J; Bracken AP
Dev Cell; 2013 Aug; 26(3):223-36. PubMed ID: 23948251
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of CHD5 Inactivation in neuroblastomas.
Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
Quan J; Yusufzai T
J Biol Chem; 2014 Jul; 289(30):20717-26. PubMed ID: 24923445
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targets for neuroblastomas.
Brodeur GM; Iyer R; Croucher JL; Zhuang T; Higashi M; Kolla V
Expert Opin Ther Targets; 2014 Mar; 18(3):277-92. PubMed ID: 24387342
[TBL] [Abstract][Full Text] [Related]
11. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
12. CHD5 is a tumor suppressor at human 1p36.
Bagchi A; Papazoglu C; Wu Y; Capurso D; Brodt M; Francis D; Bredel M; Vogel H; Mills AA
Cell; 2007 Feb; 128(3):459-75. PubMed ID: 17289567
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 1p36 candidate gene ZNF436 predicts the prognosis of neuroblastoma: a bioinformatic analysis.
Wang H; Wang X; Xu L
Ital J Pediatr; 2023 Oct; 49(1):145. PubMed ID: 37904225
[TBL] [Abstract][Full Text] [Related]
14. Pathway analysis of smoking-induced changes in buccal mucosal gene expression.
Khaleel A; Alkhawaja B; Al-Qaisi TS; Alshalabi L; Tarkhan AH
Egypt J Med Hum Genet; 2022; 23(1):69. PubMed ID: 37521848
[TBL] [Abstract][Full Text] [Related]
15. Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies.
Kohzaki M
Front Mol Biosci; 2022; 9():934042. PubMed ID: 36032672
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression and epigenetic-based role of chromodomain helicase DNA-binding 5 in hepatocellular carcinoma.
Heidari Z; Asemi-Rad A; Moudi B; Mahmoudzadeh-Sagheb H
J Int Med Res; 2022 Jul; 50(7):3000605221105344. PubMed ID: 35808817
[TBL] [Abstract][Full Text] [Related]
18. Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma.
Kuick CH; Tan JY; Jasmine D; Sumanty T; Ng AYJ; Venkatesh B; Chen H; Loh E; Jain S; Seow WY; Ng EHQ; Lian DWQ; Soh SY; Chang KTE; Chen ZX; Loh AHP
BMC Cancer; 2022 Jun; 22(1):717. PubMed ID: 35768791
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of chromodomain helicase DNA binding protein 5 (CHD5) inhibits cell proliferation and induces cell cycle arrest and apoptosis in chronic myeloid leukemia.
Xiong S; Yan Q; Peng Y; Huang S; Zhao R
Transl Cancer Res; 2021 Feb; 10(2):768-778. PubMed ID: 35116408
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variability of the Functional Domains of Chromodomains Helicase DNA-Binding (CHD) Proteins.
Cardoso AR; Lopes-Marques M; Oliveira M; Amorim A; Prata MJ; Azevedo L
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
